Analysis of cost of medical therapy in patients of metabolic syndrome: an observational study

Abstract

Background: The objective of the study was to analyze cost of medical therapy in patients of Metabolic syndrome.Methods: This was an observational study. The study was conducted by enrolling patients of the outpatient department of Medicine of Rajindra Hospital, Government Medical College, Patiala, Punjab. A total of 100 patients diagnosed with Metabolic syndrome were enrolled in the study. The total daily cost of the therapy was calculated by adding the direct cost of individual drugs taking in consideration the frequency of the drug. The daily cost of therapy was then extrapolated to calculate the monthly as well as annual cost of therapy.Results: The mean age of patients was 58.27±10.32 years. Out of a total of 100 patients, there were 57 female and 43 male patients, indicating a female preponderance of the disease. The average individual daily cost of medical therapy is INR 44.56 which upon extrapolation gives monthly and annual cost of INR 1336.90 and INR 16264.40 respectively. The cost of treatment in males is costlier than females (INR 50.09 in males versus INR 40.22 in females). The cost of treatment of age 31-40 years is INR 27.90 while it INR 36.97, 48.16 and 50.75 for age groups 41-50, 51-60 and 61-70 years. The various components of metabolic syndrome viz. diabetes mellitus, hypertension and dyslipidemia contribute differently to the cost of therapy. Daily cost of medical therapy for diabetes mellitus is INR 18.57 while for hypertension and dyslipidemia are INR 10.25 and INR 6.13 respectively.Conclusions: Chronic diseases like metabolic syndrome have a huge share of the healthcare budget. Given the fact that it is a lifestyle disease, its prevalence is likely to swell in the coming decades. Hence, formulation of preventive and innovative treatment guidelines is of utmost importance.

Circulating serum vitamin D levels in relation to metabolic syndrome in children: A systematic review and dose–response meta‐analysis of epidemiologic studies

“…The prevalence rate of MetS in children and adolescents has been estimated up to 19.2% globally in various populations 5 . According to previous reports, MetS had a huge financial burden on medical care systems every year 6,7 . Several risk factors, such as noticeable prevalence of obesity, 8,9 epidemiologic transition, 10 lifestyle changes, 11,12 and nutritional disorders, 13–15 led to the growing complication of MetS in the pediatric age group 16,17 which resulted in enormous concern over the last two decades.…”

Anxiety, Insomnia, and Memory Impairment in Metabolic Syndrome Rats Are Alleviated by the Novel Functional Ingredients from Anacardium occidentale

“…The comorbidity and bidirectional associations between MetS and psychiatric disorders have been reported [ 6 , 7 , 8 , 9 , 10 , 11 ]. It has been reported that the coexistence of MetS and psychiatric disorders such as anxiety, depression, insomnia, and memory impairment take a huge share of the healthcare budget, so these conditions have to be be considered [ 12 , 13 , 14 , 15 ]. Despite this great impact on socio-economic burdens, most psychological disorder treatments in MetS have been neglected.…”